{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:09Z","timestamp":1792788309117,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Velux foundation","award":["1123"],"award-info":[{"award-number":["1123"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Preclinical studies have recently evaluated the impact of low-dose brain radiation therapy (LD-RT) in animal models of Alzheimer\u2019s disease (AD) showing anti-amyloid and anti-inflammatory effects of this treatment. Its effectiveness varied, however, depending on the LD-RT protocol used and the stage when the treatment was applied. In this study, we aimed to evaluate the therapeutic potential of 10\u00a0Gy delivered in five daily fractions of 2\u00a0Gy (a protocol previously shown to induce an improvement of cognitive performances) in 9-month-old TgF344-AD rats, modeling at a pre-symptomatic stage of the disease. We showed that at an early stage, LD-RT was able to lower levels of the 18-kDa translocator protein (TSPO)-mediated neuroinflammation to normal ranges in addition to the secreted CLUSTERIN, another inflammatory protein also involved in A\u03b2 aggregation. In addition, we demonstrated that LD-RT reduces all amyloid forms (~\u2009\u2212\u200960 to \u2212\u200980%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u2009\n                    <jats:italic>0.01<\/jats:italic>\n                    ; soluble and aggregated forms of A\u03b2\n                    <jats:sub>40<\/jats:sub>\n                    , A\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    , and A\u03b2\n                    <jats:sub>oligomers<\/jats:sub>\n                    ). Interestingly, we showed for the first time that sAPP\u03b1 levels were improved by the treatment, showing a higher activation of the non-amyloidogenic pathway, that could favor neuronal survival. The current evidence confirms the capacity of LD-RT to successfully modulate two pathological hallmarks of AD, namely amyloid and neuroinflammation, when applied before symptoms onset.\n                  <\/jats:p>","DOI":"10.1186\/s12974-022-02673-x","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T15:05:36Z","timestamp":1671721536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Low-dose brain irradiation normalizes TSPO and CLUSTERIN levels and promotes the non-amyloidogenic pathway in pre-symptomatic TgF344-AD rats"],"prefix":"10.1186","volume":"19","author":[{"given":"Kelly","family":"Ceyz\u00e9riat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Koutsouvelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Dipasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fossey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Fabis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni B.","family":"Frisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Garibotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin B.","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"2673_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/138920311795860214","volume":"12","author":"A Mohamed","year":"2011","unstructured":"Mohamed A, Cortez L, de Chaves EP. Aggregation state and neurotoxic properties of Alzheimer \u03b2-amyloid peptide. Curr Protein Pept Sci. 2011;12:235\u201357.","journal-title":"Curr Protein Pept Sci"},{"key":"2673_CR2","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s40263-017-0483-3","volume":"31","author":"A Ardura-Fabregat","year":"2017","unstructured":"Ardura-Fabregat A, Boddeke EWGM, Boza-Serrano A, Brioschi S, Castro-Gomez S, Ceyz\u00e9riat K, et al. Targeting neuroinflammation to treat Alzheimer\u2019s disease. CNS Drugs. 2017;31:1057\u201382.","journal-title":"CNS Drugs"},{"key":"2673_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-021-02372-6","volume":"143","author":"AM Smith","year":"2022","unstructured":"Smith AM, Davey K, Tsartsalis S, Khozoie C, Fancy N, Tang SS, et al. Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u2019s pathology. Acta Neuropathol. 2022;143:75\u201391.","journal-title":"Acta Neuropathol"},{"key":"2673_CR4","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3390\/cells9091941","volume":"9","author":"BB Tournier","year":"2020","unstructured":"Tournier BB, Tsartsalis S, Ceyz\u00e9riat K, Garibotto V, Millet P. In vivo TSPO signal and neuroinflammation in Alzheimer\u2019s disease. Cells. 2020;9:1941.","journal-title":"Cells"},{"key":"2673_CR5","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1016\/j.neurobiolaging.2014.06.004","volume":"35","author":"M Orre","year":"2014","unstructured":"Orre M, Kamphuis W, Osborn LM, Jansen AHP, Kooijman L, Bossers K, et al. Isolation of glia from Alzheimer\u2019s mice reveals inflammation and dysfunction. Neurobiol Aging. 2014;35:2746\u201360.","journal-title":"Neurobiol Aging"},{"key":"2673_CR6","doi-asserted-by":"publisher","first-page":"24544","DOI":"10.1038\/srep24544","volume":"6","author":"DS Bouvier","year":"2016","unstructured":"Bouvier DS, Jones EV, Quesseveur G, Davoli MA, Tiago AF, Quirion R, et al. High resolution dissection of reactive glial nets in Alzheimer\u2019s disease. Sci Rep. 2016;6:24544.","journal-title":"Sci Rep"},{"key":"2673_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2967\/jnumed.110.087031","volume":"53","author":"SF Carter","year":"2012","unstructured":"Carter SF, Scholl M, Almkvist O, Wall A, Engler H, Langstrom B, et al. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J Nuclear Med. 2012;53:37\u201346.","journal-title":"J Nuclear Med"},{"key":"2673_CR8","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/brain\/awv404","volume":"139","author":"E Rodriguez-Vieitez","year":"2016","unstructured":"Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Scholl M, et al. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer\u2019s disease. Brain. 2016;139:922\u201336.","journal-title":"Brain"},{"key":"2673_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1742-2094-2-22","volume":"2","author":"MT Heneka","year":"2005","unstructured":"Heneka MT, Sastre M, Dumitrescu-Ozimek L, Dewachter I, Walter J, Klockgether T, et al. Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice. J Neuroinflamm. 2005;2:22.","journal-title":"J Neuroinflamm"},{"key":"2673_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s40478-018-0606-1","volume":"6","author":"K Ceyz\u00e9riat","year":"2018","unstructured":"Ceyz\u00e9riat K, Ben Haim L, Denizot A, Pommier D, Matos M, Guillemaud O, et al. Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer\u2019s disease. Acta Neuropathol Commun. 2018;6:104.","journal-title":"Acta Neuropathol Commun"},{"key":"2673_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neurobiolaging.2020.02.010","volume":"90","author":"O Guillemaud","year":"2020","unstructured":"Guillemaud O, Ceyz\u00e9riat K, Saint-Georges T, Cambon K, Petit F, Ben Haim L, et al. Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease. Neurobiol Aging. 2020;90:135\u201346.","journal-title":"Neurobiol Aging"},{"key":"2673_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.neuron.2013.12.034","volume":"81","author":"JE Burda","year":"2014","unstructured":"Burda JE, Sofroniew MV. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron. 2014;81:229\u201348.","journal-title":"Neuron"},{"key":"2673_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E. The cellular phase of Alzheimer\u2019s disease. Cell. 2016;164:603\u201315.","journal-title":"Cell"},{"key":"2673_CR14","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1093\/brain\/awt145","volume":"136","author":"WC Kreisl","year":"2013","unstructured":"Kreisl WC, Lyoo CH, McGwier M, Snow J, Jenko KJ, Kimura N, et al. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer\u2019s disease. Brain. 2013;136:2228\u201338.","journal-title":"Brain"},{"key":"2673_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/bs.apha.2017.08.004","volume":"82","author":"WC Kreisl","year":"2018","unstructured":"Kreisl WC, Henter ID, Innis RB. Imaging translocator protein as a biomarker of neuroinflammation in dementia. Adv Pharmacol. 2018;82:163\u201385.","journal-title":"Adv Pharmacol"},{"key":"2673_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00259-020-05166-2","volume":"49","author":"E Nutma","year":"2021","unstructured":"Nutma E, Ceyz\u00e9riat K, Amor S, Tsartsalis S, Millet P, Owen DR, et al. Cellular sources of TSPO expression in healthy and diseased brain. Eur J Nucl Med Mol Imaging. 2021;49:146\u201363.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2673_CR17","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1177\/0271678X19860408","volume":"40","author":"BB Tournier","year":"2020","unstructured":"Tournier BB, Tsartsalis S, Ceyz\u00e9riat K, Medina Z, Fraser BH, Gr\u00e9goire M-C, et al. Fluorescence-activated cell sorting to reveal the cell origin of radioligand binding. J Cereb Blood Flow Metab. 2020;40:1242\u201355.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2673_CR18","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3233\/JAD-200136","volume":"77","author":"BB Tournier","year":"2020","unstructured":"Tournier BB, Tsartsalis S, Ceyz\u00e9riat K, Fraser BH, Gr\u00e9goire M-C, K\u00f6vari E, et al. Astrocytic TSPO upregulation appears before microglial TSPO in Alzheimer\u2019s disease. J Alzheimers Dis. 2020;77:1043\u201356.","journal-title":"J Alzheimers Dis"},{"key":"2673_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2174\/1567205017666200304085513","volume":"17","author":"K Ceyz\u00e9riat","year":"2020","unstructured":"Ceyz\u00e9riat K, Zilli T, Millet P, Frisoni GB, Garibotto V, Tournier BB. Learning from the past: a review of clinical trials targeting amyloid, tau and neuroinflammation in Alzheimer\u2019s disease. Curr Alzheimer Res. 2020;17:112\u201325.","journal-title":"Curr Alzheimer Res"},{"key":"2673_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3233\/JAD-190984","volume":"74","author":"K Ceyz\u00e9riat","year":"2020","unstructured":"Ceyz\u00e9riat K, Tournier BB, Millet P, Frisoni GB, Garibotto V, Zilli T. Low-dose radiation therapy: a new treatment strategy for Alzheimer\u2019s disease? J Alzheimers Dis. 2020;74:411\u20139.","journal-title":"J Alzheimers Dis"},{"key":"2673_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.radonc.2015.10.019","volume":"118","author":"B Marples","year":"2016","unstructured":"Marples B, McGee M, Callan S, Bowen SE, Thibodeau BJ, Michael DB, et al. Cranial irradiation significantly reduces beta amyloid plaques in the brain and improves cognition in a murine model of Alzheimer\u2019s Disease (AD). Radiother Oncol. 2016;118:43\u201351.","journal-title":"Radiother Oncol"},{"key":"2673_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/JAD-200030","volume":"75","author":"GD Wilson","year":"2020","unstructured":"Wilson GD, Wilson TG, Hanna A, Fontanesi G, Kulchycki J, Buelow K, et al. Low dose brain irradiation reduces amyloid-\u03b2 and Tau in 3xTg-AD mice. J Alzheimers Dis. 2020;75:15\u201321.","journal-title":"J Alzheimers Dis"},{"key":"2673_CR23","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.3390\/ijms21124532","volume":"21","author":"S Kim","year":"2020","unstructured":"Kim S, Chung H, Ngoc Mai H, Nam Y, Shin SJ, Park YH, et al. Low-dose ionizing radiation modulates microglia phenotypes in the models of Alzheimer\u2019s disease. Int J Mol Sci. 2020;21:4532.","journal-title":"Int J Mol Sci"},{"key":"2673_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neurobiolaging.2021.03.008","volume":"103","author":"K Ceyz\u00e9riat","year":"2021","unstructured":"Ceyz\u00e9riat K, Zilli T, Fall AB, Millet P, Koutsouvelis N, Dipasquale G, et al. Treatment by low-dose brain radiation therapy improves memory performances without changes of the amyloid load in the TgF344-AD rat model. Neurobiol Aging. 2021;103:117\u201327.","journal-title":"Neurobiol Aging"},{"key":"2673_CR25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.ijrobp.2021.06.012","volume":"111","author":"E-J Yang","year":"2021","unstructured":"Yang E-J, Kim H, Choi Y, Kim HJ, Kim JH, Yoon J, et al. Modulation of neuroinflammation by low-dose radiation therapy in an animal model of Alzheimer\u2019s disease. Int J Radiat Oncol Biol Phys. 2021;111:658\u201370.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2673_CR26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3233\/JAD-215510","volume":"86","author":"K Ceyz\u00e9riat","year":"2022","unstructured":"Ceyz\u00e9riat K, Tournier BB, Millet P, Dipasquale G, Koutsouvelis N, Frisoni GB, et al. Low-dose radiation therapy reduces amyloid load in young 3xTg-AD mice. J Alzheimers Dis. 2022;86:641\u201353.","journal-title":"J Alzheimers Dis"},{"key":"2673_CR27","doi-asserted-by":"publisher","first-page":"E3678","DOI":"10.3390\/ijms21103678","volume":"21","author":"S Kim","year":"2020","unstructured":"Kim S, Nam Y, Kim C, Lee H, Hong S, Kim HS, et al. Neuroprotective and anti-inflammatory effects of low-moderate dose ionizing radiation in models of Alzheimer\u2019s disease. Int J Mol Sci. 2020;21:E3678.","journal-title":"Int J Mol Sci"},{"key":"2673_CR28","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1523\/JNEUROSCI.3672-12.2013","volume":"33","author":"RM Cohen","year":"2013","unstructured":"Cohen RM, Rezai-Zadeh K, Weitz TM, Rentsendorj A, Gate D, Spivak I, et al. A transgenic alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric a\u03b2, and Frank neuronal loss. J Neurosci. 2013;33:6245\u201356.","journal-title":"J Neurosci"},{"key":"2673_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.zemedi.2020.03.004","volume":"30","author":"N Koutsouvelis","year":"2020","unstructured":"Koutsouvelis N, Rouzaud M, Dubouloz A, Nouet P, Jaccard M, Garibotto V, et al. 3D printing for dosimetric optimization and quality assurance in small animal irradiations using megavoltage X-rays. Z Med Phys. 2020;30:227\u201335.","journal-title":"Z Med Phys"},{"key":"2673_CR30","doi-asserted-by":"crossref","unstructured":"Ashby D. Practical statistics for medical research. Douglas G. Altman, Chapman and Hall, London, 1991. No. of pages: 611. Price: \u00a332.00. Statistics in Medicine. 1991;10:1635\u20136.","DOI":"10.1002\/sim.4780101015"},{"key":"2673_CR31","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fgene.2019.00260","volume":"10","author":"N Narendran","year":"2019","unstructured":"Narendran N, Luzhna L, Kovalchuk O. Sex difference of radiation response in occupational and accidental exposure. Front Genet. 2019;10:260.","journal-title":"Front Genet"},{"key":"2673_CR32","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.4049\/jimmunol.181.6.3877","volume":"181","author":"M Yamamoto","year":"2008","unstructured":"Yamamoto M, Kiyota T, Walsh SM, Liu J, Kipnis J, Ikezu T. Cytokine-mediated inhibition of fibrillar amyloid-\u03b2 peptide degradation by human mononuclear phagocytes. J Immunol. 2008;181:3877\u201386.","journal-title":"J Immunol"},{"key":"2673_CR33","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1096\/fj.10-155317","volume":"24","author":"T Kiyota","year":"2010","unstructured":"Kiyota T, Okuyama S, Swan RJ, Jacobsen MT, Gendelman HE, Ikezu T. CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer\u2019s disease-like pathogenesis in APP+PS1 bigenic mice. FASEB J. 2010;24:3093\u2013102.","journal-title":"FASEB J"},{"key":"2673_CR34","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","volume":"33","author":"S Ghosh","year":"2013","unstructured":"Ghosh S, Wu MD, Shaftel SS, Kyrkanides S, LaFerla FM, Olschowka JA, et al. Sustained interleukin-1\u03b2 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer\u2019s mouse model. J Neurosci. 2013;33:5053\u201364.","journal-title":"J Neurosci"},{"key":"2673_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1742-2094-9-106","volume":"9","author":"D Tweedie","year":"2012","unstructured":"Tweedie D, Ferguson RA, Fishman K, Frankola KA, Van Praag H, Holloway HW, et al. Tumor necrosis factor-\u03b1 synthesis inhibitor 3,6\u2019-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer\u2019s disease. J Neuroinflamm. 2012;9:106.","journal-title":"J Neuroinflamm"},{"key":"2673_CR36","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/nm.2965","volume":"18","author":"J Vom Berg","year":"2012","unstructured":"Vom Berg J, Prokop S, Miller KR, Obst J, K\u00e4lin RE, Lopategui-Cabezas I, et al. Inhibition of IL-12\/IL-23 signaling reduces Alzheimer\u2019s disease-like pathology and cognitive decline. Nat Med. 2012;18:1812\u20139.","journal-title":"Nat Med"},{"key":"2673_CR37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrn.2015.29","volume":"17","author":"V Budnik","year":"2016","unstructured":"Budnik V, Ruiz-Ca\u00f1ada C, Wendler F. Extracellular vesicles round off communication in the nervous system. Nat Rev Neurosci. 2016;17:160\u201372.","journal-title":"Nat Rev Neurosci"},{"key":"2673_CR38","doi-asserted-by":"publisher","first-page":"tkab043","DOI":"10.1093\/burnst\/tkab043","volume":"10","author":"S Dai","year":"2022","unstructured":"Dai S, Wen Y, Luo P, Ma L, Liu Y, Ai J, et al. Therapeutic implications of exosomes in the treatment of radiation injury. Burns Trauma. 2022;10:tkab043.","journal-title":"Burns Trauma."},{"key":"2673_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12967-022-03392-w","volume":"20","author":"H Sun","year":"2022","unstructured":"Sun H, Sun R, Song X, Gu W, Shao Y. Mechanism and clinical value of exosomes and exosomal contents in regulating solid tumor radiosensitivity. J Transl Med. 2022;20:189.","journal-title":"J Transl Med"},{"issue":"Suppl 1","key":"2673_CR40","first-page":"S87","volume":"33","author":"AP Sagare","year":"2013","unstructured":"Sagare AP, Bell RD, Zlokovic BV. Neurovascular defects and faulty amyloid-\u03b2 vascular clearance in Alzheimer\u2019s disease. J Alzheimers Dis. 2013;33(Suppl 1):S87-100.","journal-title":"J Alzheimers Dis"},{"key":"2673_CR41","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1007\/s00018-019-03404-x","volume":"77","author":"NJ Dar","year":"2020","unstructured":"Dar NJ, Glazner GW. Deciphering the neuroprotective and neurogenic potential of soluble amyloid precursor protein alpha (sAPP\u03b1). Cell Mol Life Sci. 2020;77:2315\u201330.","journal-title":"Cell Mol Life Sci"},{"key":"2673_CR42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"2673_CR43","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1523\/JNEUROSCI.3516-14.2015","volume":"35","author":"L Ben Haim","year":"2015","unstructured":"Ben Haim L, Ceyzeriat K, Carrillo-de Sauvage MA, Aubry F, Auregan G, Guillermier M, et al. The JAK\/STAT3 Pathway Is a Common Inducer of Astrocyte Reactivity in Alzheimer\u2019s and Huntington\u2019s Diseases. J Neurosci. 2015;35:2817\u201329.","journal-title":"J Neurosci"},{"key":"2673_CR44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuroscience.2016.05.043","volume":"330","author":"K Ceyz\u00e9riat","year":"2016","unstructured":"Ceyz\u00e9riat K, Abjean L, Carrillo-de Sauvage M-A, Ben Haim L, Escartin C. The complex STATes of astrocyte reactivity: How are they controlled by the JAK-STAT3 pathway? Neuroscience. 2016;330:205\u201318.","journal-title":"Neuroscience"},{"key":"2673_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2990.1976.tb00488.x","volume":"2","author":"A Bignami","year":"1976","unstructured":"Bignami A, Dahl D. The astroglial response to stabbing. Immunofluorescence studies with antibodies to astrocyte-specific protein (GFA) in mammalian and submammalian vertebrates. Neuropathol Appl Neuro. 1976;2:99\u2013110.","journal-title":"Neuropathol Appl Neuro"},{"key":"2673_CR46","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.7150\/thno.56059","volume":"11","author":"AM Chaney","year":"2021","unstructured":"Chaney AM, Lopez-Picon FR, Serri\u00e8re S, Wang R, Bochicchio D, Webb SD, et al. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study. Theranostics. 2021;11:6644\u201367.","journal-title":"Theranostics"},{"key":"2673_CR47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neurobiolaging.2019.10.025","volume":"89","author":"CE Shepherd","year":"2020","unstructured":"Shepherd CE, Affleck AJ, Bahar AY, Carew-Jones F, Halliday GM. Intracellular and secreted forms of clusterin are elevated early in Alzheimer\u2019s disease and associate with both A\u03b2 and tau pathology. Neurobiol Aging. 2020;89:129\u201331.","journal-title":"Neurobiol Aging"},{"key":"2673_CR48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnins.2019.00164","volume":"13","author":"EM Foster","year":"2019","unstructured":"Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ. Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci. 2019;13:164.","journal-title":"Front Neurosci"},{"key":"2673_CR49","doi-asserted-by":"publisher","first-page":"10843","DOI":"10.1073\/pnas.162228299","volume":"99","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, O\u2019dell MA, Parsadanian M, Taylor JW, Harmony JAK, Bales KR, et al. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2002;99:10843\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2673_CR50","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3389\/fnins.2018.00504","volume":"12","author":"JP Robbins","year":"2018","unstructured":"Robbins JP, Perfect L, Ribe EM, Maresca M, Dangla-Valls A, Foster EM, et al. Clusterin is required for \u03b2-amyloid toxicity in human iPSC-derived neurons. Front Neurosci. 2018;12:504.","journal-title":"Front Neurosci"},{"key":"2673_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41514-018-0033-3","volume":"5","author":"JR Voorhees","year":"2019","unstructured":"Voorhees JR, Remy MT, Erickson CM, Dutca LM, Brat DJ, Pieper AA. Occupational-like organophosphate exposure disrupts microglia and accelerates deficits in a rat model of Alzheimer\u2019s disease. NPJ Aging Mech Dis. 2019;5:3.","journal-title":"NPJ Aging Mech Dis"},{"key":"2673_CR52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnagi.2019.00025","volume":"11","author":"BM Bettcher","year":"2019","unstructured":"Bettcher BM, Neuhaus J, Wynn MJ, Elahi FM, Casaletto KB, Saloner R, et al. Increases in a pro-inflammatory chemokine, MCP-1, are related to decreases in memory over time. Front Aging Neurosci. 2019;11:25","journal-title":"Front Aging Neurosci."},{"key":"2673_CR53","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41598-018-19807-y","volume":"8","author":"W-J Lee","year":"2018","unstructured":"Lee W-J, Liao Y-C, Wang Y-F, Lin I-F, Wang S-J, Fuh J-L. Plasma MCP-1 and cognitive decline in patients with Alzheimer\u2019s disease and mild cognitive impairment: a two-year follow-up study. Sci Rep. 2018;8:1280.","journal-title":"Sci Rep"},{"key":"2673_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13195-021-00940-2","volume":"14","author":"JL Sanchez-Sanchez","year":"2022","unstructured":"Sanchez-Sanchez JL, Giudici KV, Guyonnet S, Delrieu J, Li Y, Bateman RJ, et al. Plasma MCP-1 and changes on cognitive function in community-dwelling older adults. Alzheimer\u2019s Res Ther. 2022;14:5.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"2673_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006197","volume":"4","author":"T Kiyota","year":"2009","unstructured":"Kiyota T, Yamamoto M, Xiong H, Lambert MP, Klein WL, Gendelman HE, et al. CCL2 accelerates microglia-mediated Abeta oligomer formation and progression of neurocognitive dysfunction. PLoS ONE. 2009;4: e6197.","journal-title":"PLoS ONE"},{"key":"2673_CR56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nbd.2018.09.022","volume":"121","author":"BB Tournier","year":"2019","unstructured":"Tournier BB, Tsartsalis S, Rigaud D, Fossey C, Cailly T, Fabis F, et al. TSPO and amyloid deposits in sub-regions of the hippocampus in the 3xTgAD mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2019;121:95\u2013105.","journal-title":"Neurobiol Dis"},{"key":"2673_CR57","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jphs.2019.03.007","volume":"140","author":"K Toyama","year":"2019","unstructured":"Toyama K, Spin JM, Abe Y, Suzuki Y, Deng AC, Wagenh\u00e4user MU, et al. Controlled isoflurane anesthesia exposure is required for reliable behavioral testing in murine surgical models. J Pharmacol Sci. 2019;140:106\u20138.","journal-title":"J Pharmacol Sci"},{"key":"2673_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179588","volume":"12","author":"K Hohlbaum","year":"2017","unstructured":"Hohlbaum K, Bert B, Dietze S, Palme R, Fink H, Th\u00f6ne-Reineke C. Severity classification of repeated isoflurane anesthesia in C57BL\/6JRj mice-assessing the degree of distress. PLoS ONE. 2017;12: e0179588.","journal-title":"PLoS ONE"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02673-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-022-02673-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02673-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T16:02:35Z","timestamp":1671724955000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-022-02673-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2673"],"URL":"https:\/\/doi.org\/10.1186\/s12974-022-02673-x","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"assertion":[{"value":"25 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Ethics Committee for Animal Experimentation of the Canton of Geneva, Switzerland (GE9917). All experiments complied with the Animal Research: Reporting\u00a0In vivo\u00a0Experiments (ARRIVE) guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"311"}}